Literature DB >> 20689213

Central serous chorioretinopathy and endogenous cortisol - is there an association?

Charudatt Chalisgaonkar, Siddharth Chouhan, Sujata Lakhtakia, Pankaj Choudhary, P C Dwivedi, M K Rathore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20689213      PMCID: PMC2992936          DOI: 10.4103/0301-4738.67055

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Dear Editor, We read the article of Zakir et al.[1] titled ″Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy″ with interest, published in the Indian Journal of Ophthalmology. In their study, the mean serum cortisol value of 23 central serous chorioretinopathy (CSCR) patients was compared with that of only 12 controls. For the best comparison of mean values, the number of test and control subjects should be same. In their study only two out of 23 CSCR patients were having serum cortisol levels outside normal limit. Though the mean serum cortisol value of CSCR patients was found to be higher than that of control patients, endogenous cortisol may not act pathologically unless it is outside normal range. Further, only morning blood samples were investigated. This may affect the final mean cortisol values of study subjects as endogenous cortisol shows diurnal variations. This fluctuation varies from individual to individual. Hence for accurate assessment of endogenous cortisol, both morning and evening samples should be taken. We also have conducted a similar study but with opposite result titled ″Central serous chorioretinopathy and endogenous cortisol – is there an association?″ which was presented as a free paper at the Madhya Pradesh State Ophthalmic Society (MPSOS) conference, October 2009, held at Bhopal. In our study we compared serum cortisol levels of 37 consecutive patients of acute CSCR and 32 patients presenting with sudden painless diminution of vision without CSCR as controls. Patients with conditions altering the endogenous cortisol levels were excluded from the study. In our study serum cortisol estimation was done by Chemi-luminescent Immuno-assay taking venous blood samples at 8.00 am and 4.00 pm from both groups. The mean value of 8.00 a.m. serum cortisol in test group was 8.76 µg/dl compared to 8.53 µg/dl in control group, the difference being statistically not significant (P=0.975). The mean value of 4.00 p.m. serum cortisol in CSCR patients was 6.13 µg/dl and 6.07 µg/dl in controls. This difference was also statistically insignificant (P=0.948). Our observations are in accordance with those of Haimovici et al.[2] and Akira et al.[3] The corticosteroids generally strengthen tight junctions and reduce blood-brain and blood-retinal barrier breakdown. They also decrease vascular permeability. As such they should have no role to play in the pathogenesis of CSCR. But authors supporting the positive role of cortisol in CSCR postulate that cortisol paradoxically may cause increased angiographically documented retinal pigment epithelium and choroidal permeability.[4] However, the precise mechanism regarding their direct contribution to the development or worsening of CSCR remains speculative. Our study did not find a precise correlation of serum cortisol with CSCR. However, continued attention to this clinically interesting disease entity in terms of endocrinological association may lead to its better understanding in the future. Till such time, it can be said that the association of endogenous cortisol with CSCR, though probable still remains inconsistent and there may be other contributory pathogenic mechanisms which need further evaluation.
  3 in total

1.  Endocrine abnormalities in patients with central serous chorioretinopathy.

Authors:  Robert Haimovici; Shimon Rumelt; James Melby
Journal:  Ophthalmology       Date:  2003-04       Impact factor: 12.079

2.  Endogenous cortisol profile in patients with central serous chorioretinopathy.

Authors:  S P Garg; T Dada; D Talwar; N R Biswas
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

3.  Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy.

Authors:  Shaik M Zakir; M Shukla; Zaka-Ur-Rab Simi; J Ahmad; Mahmood Sajid
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

  3 in total
  6 in total

1.  The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.

Authors:  Emine Çiloğlu; Fikret Unal; Nese Cetin Dogan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-18       Impact factor: 3.117

2.  Corticosteroids usage and central serous chorioretinopathy: a meta-analysis.

Authors:  Ge Ge; Yun Zhang; Yichi Zhang; Zhihui Xu; Meixia Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-16       Impact factor: 3.117

3.  A novel mutation of sgk-1 gene in central serous chorioretinopathy.

Authors:  Mahmut Akyol; Muhammet Kazım Erol; Ozdemir Ozdemir; Deniz Turgut Coban; Ahmet Burak Bilgin; Esin Sogutlu Sari; Elif Betul Turkoglu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

4.  Comparison of Serum Cortisol and Testosterone Levels in Acute and Chronic Central Serous Chorioretinopathy.

Authors:  Tanie Natung; Avonuo Keditsu
Journal:  Korean J Ophthalmol       Date:  2015-11-25

5.  Central Serous Chorioretinopathy and Blood Serotonin Concentrations.

Authors:  Takeshi Kimura; Takashi Araki; Yuki Komuku; Hisashi Iwami; Fumi Gomi
Journal:  J Clin Med       Date:  2021-02-03       Impact factor: 4.241

6.  Stress and vision-related quality of life in acute and chronic central serous chorioretinopathy.

Authors:  Meenakshi Kumar; Elon H C van Dijk; Rajiv Raman; Pooja Mehta; Camiel J F Boon; Abhilash Goud; Seelam Bharani; Jay Chhablani
Journal:  BMC Ophthalmol       Date:  2020-03-06       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.